Brain abscesses are mainly caused by either direct or indirect inoculation of gram positive bacteria including Stapylococcus aureus (S. aureus) or Streptococcus species into the central nervous system. In the present study, we aimed to compare potential changes in brain abscess pathogenesis induced by two different strains of S. aureus, namely the laboratory strain RN6390 and the clinical isolate Reynolds. Although the Reynolds strain was expected to be more resistant to eradication by the host, due to the existence of a polysaccharide capsule, and subsequently to be more virulent, instead we found parenchymal damage and mortality rates to be more prominent following RN6390 infection. In contrast, the Reynolds strain proliferated faster and induced early expression of the chemokine CXCL2, matrix metalloproteinase-9 (MMP-9), and complement 3a and C5. Furthermore, there were early and more abundant infiltration of PMNs, T cells and erythrocyte extravasation in brain abscesses induced by the Reynolds strain. However, several immune parameters were not different between the two strains during the later stages of the disease. These results suggest that capsular S. aureus can modulate innate immunity and complement system activation differently than the acapsular strain RN6390, and the early changes induced by Reynolds strain may have an important impact on survival.
Introduction
Staphylococcus aureus (S. aureus) is an opportunistic gram positive bacterium that causes a wide spectrum of clinical manifestations, ranging from localized soft-tissue infections to life-threatening bacteremia, endocarditis, and abscesses within multiple organs including the brain (Archer, 1998; Lowy, 1998; Townsend and Scheld, 1998) . Many virulence factors contribute to the pathogenesis of staphylococcal infections including both bacterial structural components and secreted products such as surface-associated adhesion molecules, exoenzymes, exotoxins, and capsular polysaccharides (Projan and Novick, 1997) . Capsular polysaccharides (CP) are produced by more than 90% of all S. aureus isolates (O' Riordan and Lee, 2004 ). In addition, serotyping studies reveal that CP5 and CP8 are the predominant polysaccharides of those isolates recovered from humans with virulent S. aureus infections (25% and 50%, respectively) (Hochkeppel et al., 1987; Sompolinsky et al., 1985) .
Abscesses in brain parenchyma develop as a consequence of local spread of pyogenic bacteria from the paranasal sinuses, middle ear, or oral cavity, via hematogenous dissemination from a systemic infection (e.g. endocarditis), or by direct penetrating trauma to the head. The most common etiologies of brain abscess are the streptococcal species and S. aureus (Mathisen and Johnson, 1997; Townsend and Scheld, 1998) .
During the last decade, an experimental brain abscess model in rats and mice has been established by direct intra-cerebral injection of live S. aureus (Flaris and Hickey, 1992; Kielian and Hickey, 2000) . This system has been investigated intensely to understand the mechanisms in disease pathogenesis and the possible treatment modalities (Flaris and Hickey, 1992; Kielian and Hickey, 2000) . It mimics accurately the natural course of brain abscess development in humans. Thus, during the early stage of brain abscess development (days 1-3), microglial and astrocyte activation, as well as neutrophil accumulation become evident, and are accompanied by subsequent tissue necrosis, and edema. Microglial and astrocyte activation is observed in all stages throughout abscess development. Predominant infiltration of macrophages and lymphocytes is observed from days 4-9 and characterizes the intermediate or late cerebritis stage. At the final or capsule stage (days 10 onward), a well-vascularized abscess wall is formed, sequestering the lesion and protecting the surrounding normal brain parenchyma from additional damage. Although RN6390, derived from the strain NCTC 8325, is widely used in several disease models due to the fact it is amenable to genetic manipulation, it is a laboratory strain and is quite different than the strains isolated from clinical cases. One important difference is the absence of capsular structure outside the bacteria. In addition, RN6390 has known mutations which affect its virulence (Blevins et al., 2002; Cassat et al., 2006) . Moreover, Journal of Neuroimmunology 218 (2010) [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] 
